NEW YORK (GenomeWeb) – Danaher today initiated its 2018 outlook, saying earnings per share is anticipated to be in the range of $3.50 to $3.60.

On an adjusted basis, EPS was guided to a range of $4.25 to $4.35, which assumes revenue growth of between 3.5 percent and 4 percent, the company said. The consensus Wall Street estimate for 2018 is for EPS of $4.34.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.